Question 1

Does MetLife Investment Management own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, MetLife Investment Management holds 89,662 shares of AXSM (Axsome Therapeutics), worth $21.9M.

Question 2

How many shares of AXSM does MetLife Investment Management own?

Accepted Answer

As of its Q2 2026 13F, MetLife Investment Management holds 89,662 shares of AXSM (Axsome Therapeutics).

Question 3

What is MetLife Investment Management's AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, MetLife Investment Management's AXSM position is worth $21.9M.

Question 4

Is MetLife Investment Management buying or selling AXSM?

Accepted Answer

In Q2 2026, MetLife Investment Management reduced its AXSM position by 62,983 shares (-41.3%).

Question 5

When did MetLife Investment Management first buy AXSM?

Accepted Answer

MetLife Investment Management first reported AXSM in its Q2 2019 13F and has listed it in 29 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	89,662	-41.3%	$21.9M	0.1%	$244.77	0
2026-Q1	Decreased	152,645	-7.4%	$25.8M	0.1%	$169.02	0
2025-Q4	Decreased	164,871	-16.4%	$30.1M	0.1%	$182.64	0
2025-Q3	Increased	197,318	+7.1%	$24M	0.1%	$121.45	37
2025-Q2	Increased	184,164	+2.9%	$19.2M	0.1%	$104.39	35
2025-Q1	Increased	178,955	+703.3%	$20.9M	0.1%	$116.63	55
2024-Q4	Increased	22,277	+5.8%	$1.9M	0.0%	$84.61	27
2024-Q3	Unchanged	21,045	0.0%	$1.9M	0.0%	$89.87	0